Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
O^6-alkylguanine-DNA alkyltransferase (AGT), also known as O^6-methylguanine-DNA methyltransferase (MGMT), is a DNA repair enzyme that removes alkyl groups from the O^6 position of guanine in DNA. The SNAP-tag is a self-labeling protein tag derived from AGT that can be genetically fused to any protein of interest, enabling site-specific covalent labeling with synthetic molecules. It is used in antibody-directed targeting strategies and has been explored in cancer therapy and adoptive cell therapies.
The SNAP-tag reacts specifically and covalently with substrates containing an O^6-benzylguanine (BG) moiety. Upon reaction, the tag forms a stable thioether bond between a reactive cysteine residue in the tag and the BG derivative.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O^6-alkylguanine-DNA alkyltransferase (AGT).